What does europe — indefinite-lived intangible assets mean?

This metric represents the carrying value of intangible assets, such as acquired in-process research and development or trade names, that are attributed to the European segment and have no foreseeable limit on their cash flow generation. These assets are not amortized but are subject to annual impairment testing to ensure their book value does not exceed their fair market value. It reflects the company's long-term investment in intellectual property and strategic assets specifically tied to the European market's growth potential.

BioMarin Pharmaceuticals BMRN Europe — Indefinite-lived intangible assets

Discontinued — last reported Q4 '18

Similar metrics at other companies

CCLEurope Segment — Indefinite-Lived Intangible Assets (Excluding Goodwill)

$253M+8.6%

SSD

SSDEurope — Intangibles (Net)

$299.12M-0.9%

SSD

SSDEurope — Finite-Lived Intangible Assets, Accumulated Amortization

$97.33M+26.1%

CBOEEurope and Asia Pacific — Finite-lived intangible assets, gross

$202.2M-5.9%

CBOEEurope and Asia Pacific — Indefinite-lived intangible assets, gross

$215M+1.8%

TEC

TECHEurope — Intangible Assets Net Excluding Goodwill

$63.63M+0.8%

Other financials

Income statement

See full

Revenue$766.2M+2.8%

Gross profit$571.2M-3.8%

Operating income$129.6M-42.1%

Net income$105.5M-43.2%

EPS (diluted)$0.54-43.2%

Balance sheet

See full

Cash & equivalents$3.1B+193%

Total debt$1.4B+138%

Total equity$6.2B+7.2%

Total assets$8.6B+20.2%

Cash flow

See full

Operating cash flow$220.7M+26.5%

CapEx$20.9M+24.8%

Free cash flow$199.7M+26.7%

Valuation

See full

Market cap$10.57B-19.4%

Enterprise value$8.93B-29.3%

P/E21.1×-22.7×

P/S3.3×-1.2×

Profitability

See full

Gross margin76.5%-2.9pp

Operating margin19.9%+7.2pp

Net margin16.8%+5.1pp

FCF margin23.7%+2.5pp

Returns & leverage

See full

Return on equity9.1%+2.8pp

Debt / equity0.2×+0.1×

Current ratio5.8×+0.3×

Where this comes from

Reported directly by BioMarin Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill.

The official record: BioMarin Pharmaceuticals’s 10-K, filed February 27, 2020, on SEC EDGAR. View the filing →

Questions, answered.

What does europe — indefinite-lived intangible assets mean?: This metric represents the carrying value of intangible assets, such as acquired in-process research and development or trade names, that are attributed to the European segment and have no foreseeable limit on their cash flow generation. These assets are not amortized but are subject to annual impairment testing to ensure their book value does not exceed their fair market value. It reflects the company's long-term investment in intellectual property and strategic assets specifically tied to the European market's growth potential.